Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the Sao Paulo-Toronto Hemophilia Study
dc.contributor.author | Carneiro, J. D. A. | |
dc.contributor.author | Blanchette, V. | |
dc.contributor.author | Ozelo, M. C. | |
dc.contributor.author | Antunes, S. V. [UNIFESP] | |
dc.contributor.author | Villaca, P. R. | |
dc.contributor.author | Young, N. L. | |
dc.contributor.author | Castro, D. | |
dc.contributor.author | Brandao, L. R. | |
dc.contributor.author | Carcao, M. | |
dc.contributor.author | Abad, A. | |
dc.contributor.author | Feldman, B. M. | |
dc.date.accessioned | 2019-08-19T11:48:33Z | |
dc.date.available | 2019-08-19T11:48:33Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Introduction: Although the regular replacement of clotting factor concentrates (prophylaxis) has been well established as the standard of care for severe haemophilia, the high cost of factor concentrates has limited access to prophylaxis in countries with under-developed or developing economies. Aims: We studied the health gap that could be addressed by providing unlimited access to clotting factor concentrates with implementation of long-term prophylaxis initiated from an early age in life. Methods: We performed a cross-sectional study of a random, representative sample of boys with moderate and severe haemophilia at three haemophilia treatment centres in Sao Paulo, Brazil, and one centre in Toronto, Canada. Results: Canadian subjects were more often treated with prophylaxis, and began treatment at an earlier age. Fewer Canadian subjects had bleeds within the preceding 6 months (19 vs. 34, P = 0.003). Canadian subjects had lower (better) Pettersson radiographic scores (1.5 vs. 6.0, P = 0.0016), lower (better) Hemophilia Joint Health Scores (5.5 vs. 10.5, P = 0.0038), higher (better) Activity Scale for Kids scores (96.6 vs. 92.0, P = 0.033), more time spent in vigorous activity, and higher (better) social participation scores. Conclusions: Our findings suggest that increasing access to clotting factor concentrates for young boys with severe haemophilia is a global imperative. | en |
dc.description.affiliation | Univ São Paulo, Ctr Hemofilia, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Crianca, Hosp Clinicas, Fac Med, São Paulo, Brazil | |
dc.description.affiliation | Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada | |
dc.description.affiliation | Univ Toronto, Dept Pediat, Toronto, ON, Canada | |
dc.description.affiliation | Univ Estadual Campinas, Unit Hemophilia IHTC Claudio LP Correa, INCT Sangue Hemoctr Unicamp, Campinas, SP, Brazil | |
dc.description.affiliation | Univ Fed São Paulo UNIFESP, Dept Hematol, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Hosp Clin, Serv Hematol, Fac Med, São Paulo, Brazil | |
dc.description.affiliation | Laurentian Univ, Sch Rural & Northern Hlth, Sudbury, ON, Canada | |
dc.description.affiliation | Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada | |
dc.description.affiliation | Hosp Sick Children, Div Hematol Oncol, Dept Pediat, Toronto, ON, Canada | |
dc.description.affiliation | Hosp Sick Children, Dept Child Hlth Evaluat Sci, Toronto, ON, Canada | |
dc.description.affiliation | Hosp Sick Children, Div Rheumatol, Dept Pediat, Toronto, ON, Canada | |
dc.description.affiliation | Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada | |
dc.description.affiliationUnifesp | Univ Fed São Paulo UNIFESP, Dept Hematol, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Baxalta US Inc. Corporation through the Baxalta | |
dc.format.extent | 682-688 | |
dc.identifier | http://dx.doi.org/10.1111/hae.13230 | |
dc.identifier.citation | Haemophilia. Hoboken, v. 23, n. 5, p. 682-688, 2017. | |
dc.identifier.doi | 10.1111/hae.13230 | |
dc.identifier.issn | 1351-8216 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/51279 | |
dc.identifier.wos | WOS:000411824500031 | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | factor VIII and IX | en |
dc.subject | global health | en |
dc.subject | haemophilia | en |
dc.subject | outcome measures | en |
dc.subject | prophylaxis | en |
dc.title | Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the Sao Paulo-Toronto Hemophilia Study | en |
dc.type | info:eu-repo/semantics/article |